Id: | acc2433 |
Group: | 2sens |
Protein: | H2AX |
Gene Symbol: | H2AX |
Protein Id: | P16104 |
Protein Name: | H2AX_HUMAN |
PTM: | phosphorylation |
Site: | Ser139 |
Site Sequence: | PSGGKKATQASQEY------- |
Disease Category: | Cancer |
Disease: | Melanoma |
Disease Subtype: | |
Disease Cellline: | RPMI7951 |
Disease Info: | |
Drug: | arsenite |
Drug Info: | - |
Effect: | modulate |
Effect Info: | As3+ induces the phosphorylation of TOPK and histone H2AX in RPMI7951 human melanoma cells and induces apoptosis of human melanoma cells. |
Note: | histone |
Score: | 3.0 |
Pubmed(PMID): | 17145805 |
Sentence Index: | 17145805_6-7 |
Sentence: | RESULTS: Melanoma cell lines expressing high levels of TOPK were more resistant to arsenite (As(3+))-induced apoptosis. As(3+) treatment induced phosphorylation of TOPK and histone H2AX in RPMI7951 human melanoma cells. |
Sequence & Structure:
MSGRGKTGGKARAKAKSRSSRAGLQFPVGRVHRLLRKGHYAERVGAGAPVYLAAVLEYLTAEILELAGNAARDNKKTRIIPRHLQLAIRNDEELNKLLGGVTIAQGGVLPNIQAVLLPKKTSATVGPKAPSGGKKATQASQEY
Select PDB:
No data.
Protein Tractability:
source: Open TargetsPTM Intensity:
source: CPTACNo data.
PTM-Disease Association:
source: PTMDResidue | Position | State | Disease | Class | PMID |
---|---|---|---|---|---|
S | 139 | U | Acute myelogenous leukemia | Phosphorylation | 33691101 |
S | 139 | U | Hepatocellular carcinoma | Phosphorylation | 25537504 |
S | 139 | U | Multiple myeloma | Phosphorylation | 35190641 |
State Note: Based on the distinct PTM states in diseases, PTMD classified all disease-associated PTMs into six classes, including whether the up-regulation (U) or down-regulation (D) of PTM levels, the absence (A) or presence (P) of PTMs, and the creation (C) or disruption (N) of PTM sites are associated with diseases.
PTM-Drug Perturbation Response:
source: DecryptMNo data.
Function score:
source: funscoRNo data.